Hi-Tech Pharmacal Co. (HITK) Beats Q4 Views on Top and Bottom

Hi-Tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q4 EPS of $1.08, $0.37 better than the analyst estimate of $0.71. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $49.33 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c